Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Healthtrust
QuintilesIMS
Dow
UBS
US Department of Justice
Julphar
Moodys
AstraZeneca

Generated: May 25, 2018

DrugPatentWatch Database Preview

PROTAMINE ZINC AND ILETIN II (PORK) Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Protamine Zinc And Iletin Ii (pork), and when can generic versions of Protamine Zinc And Iletin Ii (pork) launch?

Protamine Zinc And Iletin Ii (pork) is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in PROTAMINE ZINC AND ILETIN II (PORK) is insulin susp protamine zinc purified pork. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin susp protamine zinc purified pork profile page.
Summary for PROTAMINE ZINC AND ILETIN II (PORK)
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 71
DailyMed Link:PROTAMINE ZINC AND ILETIN II (PORK) at DailyMed
Drug patent expirations by year for PROTAMINE ZINC AND ILETIN II (PORK)

US Patents and Regulatory Information for PROTAMINE ZINC AND ILETIN II (PORK)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly PROTAMINE ZINC AND ILETIN II (PORK) insulin susp protamine zinc purified pork INJECTABLE;INJECTION 018346-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
Julphar
Chubb
Queensland Health
Cipla
Johnson and Johnson
Accenture
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.